Format

Send to

Choose Destination
Am J Health Syst Pharm. 2018 May 15;75(10):595-596. doi: 10.2146/ajhp180092.

Mitigating risk of bloodstream infection related to inpatient probiotic use.

Author information

1
Wegmans School of PharmacySt. John Fisher CollegeRochester, NYnbp09347@sjfc.edu.
2
Wegmans School of PharmacySt. John Fisher CollegeRochester, NY.

KEYWORDS:

Lactobacillus bacteremia; Saccharomyces fungemia; probiotic infection prevention

PMID:
29748296
DOI:
10.2146/ajhp180092
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Silverchair Information Systems
Loading ...
Support Center